Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | April 1, 2014 |
| Target | Silommedical Co. |
| Sector | Life Science |
| Buyer(s) | Allergan |
| Deal Type | Add-on Acquisition |
| Deal Value | 100M USD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1956 |
| Sector | Life Science |
| Employees | 31,200 |
| Revenue | 15.8B USD (2018) |
Allergan is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company was originally established in 1956 and is based in Parsippany, New Jersey.
| Deal Context for Buyer | # |
|---|---|
| Overall | 15 of 38 |
| Sector: Life Science | 9 of 23 |
| Type: Add-on Acquisition | 12 of 31 |
| Country: Thailand | 1 of 1 |
| Year: 2014 | 2 of 5 |
| Size (of disclosed) | 17 of 25 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-02-18 |
Forest Laboratories
New York, New York, United States Forest Laboratories, Inc. develops, manufactures, and sells branded forms of ethical drug products in the United States and Europe. |
Buy | $25.0B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-04-17 |
Akorn - 4 New Drug Applications
United States Akorn - 4 New Drug Applications includes Ciprofloxacin Hydrochloride Ophthalmic Solution, Levofloxacin Ophthalmic Solution and Lidocaine Hydrochloride Jelly and one product marketed under a New Drug Application: Lidocaine/Prilocaine Topical Cream. |
Buy | - |
